N-Butyldeoxygalactonojirimycin
CAS: 141206-42-0
Ref. 3D-MB04497
1mg | 131.00 € | ||
2mg | 196.00 € | ||
5mg | 352.00 € | ||
10mg | 491.00 € | ||
25mg | 1,028.00 € |
Product Information
- N-Butyl-1,5-dideoxy-1,5-imino-D-galactitolLucerastat
Competitive inhibitor of glucosylceramidase (GlcCer), which catalyses the first step in glycosphingolipid (GSL) synthesis. This compound is a promising candidate for substrate reduction therapy in Sandhoff disease, where it decreases the rate of GSL biosynthesis and counterbalances the impaired rate of ganglioside catabolism.
Chemical properties
Technical inquiry about: 3D-MB04497 N-Butyldeoxygalactonojirimycin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.